Quantum-Si incorporated
NASDAQ:QSIBiotechnology
+$0.05 today
- Market cap
- $213.79M
- Beta
- 3.17
- P/E (TTM)
- -2.1
- EPS (TTM)
- -$0.48
Volume 10.47M
Average 5.64M
QSI Net Income
Bottom-line profit after all expenses, interest, and taxes.
Quantum-Si incorporatedNASDAQ: QSI
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income remains negative
Q1 FY2026 net income was -$21.67M, compared with -$19.19M a year earlier. Trailing-twelve-month net income was -$103.82M.
Context
- Net income amounted to 4160.1% of revenue in FY2025, up 857.0 pp from a year earlier.
- Net income grew in size in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 2 analysts of -$88.9M (+12.3%) for the fiscal year ending Dec 2026, a step up from the -0.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$21.67M-23.1% QoQ
- Last fiscal yearDec 2025
- -$101.34M-0.3% YoY
- LTMMar 2026
- -$103.82M-3.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -12.9% | +13.9% | +26.9 pp |
| 1 year | -0.3% | +12.3% | +12.6 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the income statement
- Latest · FY2025
- (101.34M) USD
- Year-over-year change
- -0.3%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (101.34M) | -0.3% |
| FY2024 | 2024-12-31 | (101.01M) | -5.3% |
| FY2023 | 2023-12-31 | (95.96M) | +27.5% |
| FY2022 | 2022-12-31 | (132.44M) | -39.4% |
| FY2021 | 2021-12-31 | (94.99M) | — |
Net Income vs competitors
How QSI compares with its peers on the latest reported figures
- QSI's LTM Mar 2026 net income of -$103.82M is the 4th highest of the 11 companies compared; the peer median is -$152.42M.
- Its year-over-year change of -3.1% is the 5th highest of 10, against a peer median of -17.4%.
- Net income amounts to 5605.9% of revenue for QSI, versus a peer median of 312.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
LBRXLB Pharmaceuticals Inc Common Stock | LTM Mar 2026 | -$39.17M | — | — | — |
ENGNenGene Holdings Inc. | LTM Apr 2026 | -$66.4M | +16.9% | — | — |
| LTM Mar 2026 | -$91.08M | -0.9% | — | 253002.8% | |
| LTM Mar 2026 | -$103.82M | -3.1% | — | 5605.9% | |
| LTM Mar 2026 | -$112.39M | -18.7% | — | — | |
| LTM Mar 2026 | -$136.99M | +8.6% | — | 173.0% | |
| LTM Mar 2026 | -$167.85M | -47.7% | — | — | |
| LTM Mar 2026 | -$191.78M | -37.3% | — | — | |
| LTM Mar 2026 | -$196.48M | -17.4% | — | — | |
| LTM Mar 2026 | -$209.38M | +18.9% | — | — | |
| LTM Mar 2026 | -$288.83M | -21.3% | — | 312.0% | |
| Peer median (excluding QSI) | -$152.42M | -17.4% | — | 312.0% | |
Competitors are the stored peer set for QSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 1.08M | 3.06M | 2.44M |
| Cost of Revenue | 0 | 0 | 594K | 1.46M | 1.28M |
| Gross Profit | 0 | 0 | 488K | 1.6M | 1.15M |
| Gross Margin | — | — | 45.1% | 52.3% | 47.3% |
| Research & Development | 46.58M | 72.06M | 67.03M | 59.64M | 53.76M |
| Selling, General & Admin | 50.33M | 42.3M | 44.63M | 50.54M | 44.75M |
| Operating Expenses | 96.91M | 123.84M | 111.66M | 110.18M | 98.51M |
| Depreciation & Amortization | 1.04M | 2.58M | 4.16M | 4.6M | 4.45M |
| EBITDA | (93.94M) | (111.77M) | (91.8M) | (96.35M) | (96.83M) |
| EBITDA Margin | — | — | -8484.7% | -3150.8% | -3974.8% |
| Operating Income | (96.91M) | (123.84M) | (111.17M) | (108.58M) | (97.36M) |
| Operating Margin | — | — | -10274.6% | -3550.6% | -3996.7% |
| Interest Income | 0 | 0 | 0 | 0 | 8.96M |
| Interest Expense | 5K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 1.92M | (8.6M) | 15.21M | 7.63M | (3.92M) |
| Income Before Tax | (94.99M) | (132.44M) | (95.96M) | (100.95M) | (101.28M) |
| Pre-Tax Margin | — | — | -8868.8% | -3301.2% | -4157.7% |
| Income Tax Expense | 0 | 0 | 0 | 56K | 58K |
| Net Income | (94.99M) | (132.44M) | (95.96M) | (101.01M) | (101.34M) |
| Net Margin | — | — | -8868.8% | -3303.0% | -4160.1% |
| EPS (Basic) | (1.19) | (0.95) | (0.68) | (0.71) | (0.51) |
| EPS (Diluted) | (1.19) | (0.95) | (0.68) | (0.71) | (0.51) |
| Weighted Avg Shares | 79.58M | 139.26M | 141.3M | 143.2M | 197.77M |
| Weighted Avg Shares (Diluted) | 79.58M | 139.26M | 141.3M | 143.2M | 197.77M |
Quantum-Si incorporated
NASDAQ:QSI
Intrinsic Alpha fair value
Locked
Current Price
$1.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.